• 1
    Olsen AH, Lynge E, Njor SH, et al. Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer. 2012 Apr 24. doi:10.1002/ijc.27609. [Epub ahead of print]
  • 2
    Kalager M, Zelen M, Langmark F, et al. Effect of screening mammography on breast cancer mortality in Norway. N Engl J Med ( 2010); 363: 120310.
  • 3
    Lynge E, Braaten T, Njor SH, Olsen AH, et al. Mammography activity in Norway (1983) to (2008). Acta Oncol ( 2011); 50: 10627.
  • 4
    Kalager M, Adami HO, Bretthauer M, et al. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med ( 2012); 156: 4919.
  • 5
    Jørgensen KJ, Zahl PH, Gøtzsche PC. Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health ( 2009); 9: 36.
  • 6
    Sørum R, Hofvind S, Skaane P, et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast ( 2010); 19: 499505.
  • 7
    Jensen A, Olsen AH, von Euler-Chelpin M, et al. Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer ( 2005); 113: 46470.
  • 8
    Weedon Fekjær H, Bakken K, Vatten LJ, et al. Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment. BMJ ( 2012); 344: e299.
  • 9
    Weedon Fekjær H, Lindqvist BH, Vatten LJ, et al. Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening. J Med Screen ( 2008); 15: 8390.